The Therapeutic Goods Administration (TGA) is seeking feedback on its proposed annotations to the ICH E6 (R3) Good Clinical Practice guidelines, which will shape future clinical trial requirements in Australia.

To support a coordinated sector response, ACTA is hosting a one-hour Microsoft Teams meeting on Tuesday, 7 October, from 12:30 – 1:30 pm, facilitated by Dr Tanya Symons.

During this session, Tanya will:

· Explain the rationale for the TGA consultation

· Share examples of potential feedback to the TGA

· Gather additional input from attendees to inform a collective response

This meeting is open to all trial stakeholders, including industry and non-industry sponsor personnel, investigators, trial teams, and those involved in the ethics or governance of trials.